Infectious Disease & Respiratory

COVID-19 Clinical Research

COVID-19 continues to impact millions worldwide, creating an urgent need for advanced therapies, vaccines, and long-term recovery solutions. CenExel partners with sponsors to accelerate innovative COVID-19 clinical trials through experienced investigators, rapid enrollment capabilities, and diverse patient populations across the United States.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Advancing COVID-19 Clinical Innovation

CenExel delivers specialized clinical research solutions focused on COVID-19 prevention, treatment, and post-viral recovery. Our experienced research teams support Phase I–IV studies with rapid patient recruitment, regulatory expertise, and access to diverse communities nationwide.

We collaborate with pharmaceutical and biotechnology sponsors to help bring life-saving therapies and vaccines to market faster and more efficiently.

Conditions Covered

COVID-19 Conditions We Support

  • Acute COVID-19 Infection
  • Long COVID / Post-COVID Syndrome
  • Respiratory Complications
  • Vaccine Efficacy Studies
  • Antiviral Treatment Trials
  • Immune Response Research
  • High-Risk Population Studies
  • COVID-19 Prevention Programs
Our Approach

Why Sponsors Partner With CenExel for COVID-19 Research

Our infectious disease research teams provide rapid study startup, strong patient recruitment strategies, and experienced operational support for COVID-19 clinical trials.

01

Fast Study Activation

Accelerated IRB approvals and operational workflows help reduce study startup timelines.

02

Diverse Patient Access

Nationwide access to diverse participant populations improves enrollment quality and representation.

03

Respiratory Research Expertise

Experienced investigators support complex respiratory and infectious disease studies.

04

Reliable Data & Compliance

High-quality data collection and regulatory compliance ensure successful trial execution.

Phase Coverage

Supported Trial Phases

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

CenExel supports early and late-phase COVID-19 clinical trials — from first-in-human antiviral therapies to large-scale vaccine and post-COVID recovery studies.

COVID-19 Task Force

CenExel supports a broad range of COVID-19 clinical research studies, including antiviral therapies, vaccine development, respiratory care, and long-term recovery programs.

Active Sites

18 Sites

CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg

Our Blog